Wealth Effects LLC
- SEC CIK
- 0001907254
- Latest filing
- Aug 6, 2026
CATX holding history
Perspective Therapeutics, Inc. in every 13F filed by Wealth Effects LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CATX overviewAll 13F holders of CATXFull Q2 2026 holdings
- Shares (Q2 2026)
- 35,000
- Value
- $119.3K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 35,000 | $119.3K | <0.1% | +2,000+6.1% | Added | Holders |
| Q1 2026 | 33,000 | $137.6K | <0.1% | +8,000+32.0% | Added | Holders |
| Q4 2025 | 25,000 | $68.8K | <0.1% | −1,000−3.8% | Reduced | Holders |
| Q3 2025 | 26,000 | $89.2K | <0.1% | +2,000+8.3% | Added | Holders |
| Q2 2025 | 24,000 | $82.6K | <0.1% | −15,000−38.5% | Reduced | Holders |
| Q1 2025 | 39,000 | $83.1K | <0.1% | +1,000+2.6% | Added | Holders |
| Q4 2024 | 38,000 | $121.2K | <0.1% | +24,750+186.8% | Added | Holders |
| Q3 2024 | 13,250 | $176.9K | 0.1% | −4,100−23.6% | Reduced | Holders |
| Q2 2024 | 17,350 | $173.0K | 0.1% | −100,150−85.2% | Reduced | Holders |
| Q1 2024 | 117,500 | $139.8K | 0.1% | −2,500−2.1% | Reduced | Holders |
| Q4 2023 | 120,000 | $48.2K | <0.1% | +10,000+9.1% | Added | Holders |
| Q3 2023 | 110,000 | $30.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 110,000 | $73.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 110,000 | $70.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 110,000 | $27.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 110,000 | $25.0K | <0.1% | +100,000+1,000.0% | Added | Holders |
| Q2 2022 | 10,000 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,000 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,000 | $4.00K | <0.1% | – | No prior filing | Holders |